Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study Meeting Abstract
| Authors: | Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; Afuye, A. O.; Batlevi, C. L.; Besser, M.; Dahi, P. B.; Danylesko, I.; Giralt, S.; Imber, B. S.; Jacobi, E.; Nagler, A.; Palomba, M. L.; Salles, G.; Sauter, C. S.; Shah, G. L.; Shem-Tov, N.; Shimoni, A.; Yahalom, J.; Yerushalmi, R.; Avigdor, A.; Perales, M. A.; Shouval, R. |
| Abstract Title: | Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398803181 |
| DOI: | 10.1182/blood-2021-147568 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 883 -- Hybrid meeting, also took place online -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
